Avenue Therapeutics, Inc. ATXI
0.50
0.14
38.89%
as of 24 Sep
- Market cap
- $680.0K
- P/E
- 0.0×
Follow ATXI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.38 | 1.90 | 2.60 | 2.61 | |
Current Ratio |
1.40 | 1.94 | 2.67 | 2.62 | |
Net Debt/EBITDA |
2.75 | 3.39 | 3.80 | 5.12 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.69 | 0.63 | 1.20 | (0.56) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.14) | (0.13) | (0.27) | 0.12 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.14) | (0.13) | (0.27) | 0.12 | |
Cash per Share |
0.59 | 0.73 | 0.91 | 1.16 | |
Shareholders Equity per Share |
0.17 | 0.36 | 0.59 | 0.72 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.17 | 0.36 | 0.59 | 0.72 | |
Free Cash Flow |
(0.47) | (0.44) | (0.85) | 0.38 | |
Working Capital |
0.57 | 1.20 | 1.83 | 2.30 | |
Net Current Asset Value |
0.57 | 1.20 | 1.83 | 2.30 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.37 | 1.27 | 0.95 | 1.18 | |
Average Assets |
3.07 | 3.03 | 2.80 | 3.18 | |
Average Common Equity |
1.70 | 1.77 | 1.84 | 1.98 |
Columns are period end dates